What Happened?
Toronto, ON-based Centre for Commercialization of Regenerative Medicine Appointed Kim Warren as Chief Technology Officer
About the Company
Centre for Commercialization of Regenerative Medicine , a Canadian not-for-profit organization funded by the Government of Canada`s Networks of Centres of Excellence program, the Province of Ontario, and leading academic and industry partners, supports the development of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy. CCRM aims to accelerate the translation of scientific discovery into marketable products for patients with specialized teams funding, and infrastructure. CCRM sources and evaluates intellectual property from around the globe, offers various consulting services, conducts development projects with partners, and establishes new companies built around strategic bundles of intellectual property. CCRM is the commercialization partner of the Ontario Institute for Regenerative Medicine and the University of Toronto`s Medicine by Design. CCRM is hosted by the University of Toronto and was launched in Toronto`s Discovery District on June 14, 2011.
About the Person
Kim Warren has a Ph.D. in Comparative Physiology from Univ. of Maryland and postdoctoral training in Immunology at USUHS, Bethesda MD. Kim is an experienced scientist with entrepreneurial and business management experience, currently consulting in the field of Cell Therapy. She spent the last 10 years at Lonza, developing a services business, including tissue acquisition, process development, bioassays and related services to support GMP manufacturing of cellular therapeutics. Kim also headed R&D at Cambrex, developing cell-based research products. She founded and ran Poietic Technologies, acquired by Cambrex in 1999. She has held research positions in pharma (Otsuka) and biotech (Cetus).
Info Source
News
Short Profile